Related Experiment Videos
[A peculiar acantholytic dermatosis (author's transl)]
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantitative real-time PCR (qPCR)--based tool for detection and quantification of Cordyceps militaris in soil.
Journal of invertebrate pathology·2014
The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1.
British journal of cancer·2013
A comparative study of single-incision versus conventional multiport laparoscopic ileocecal resection for Crohn's disease with strictures.
Asian journal of endoscopic surgery·2012
Flavonol-containing phosphorylated pullulan may attenuate pulp inflammation.
International endodontic journal·2012
Establishment of an ex vivo pulpitis model by co-culturing immortalized dental pulp cells and macrophages.
International endodontic journal·2012
[Sweet's syndrome with pregnancy].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
[Generalised type of acquired dermal melanocytosis].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
[A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
[Urticarial erythema with neutrophilic infiltration--correlation of cutaneous vascular changes with clinical severity].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
[Skin penetration of antimicrobial agents in rats].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
[The partial characterization of neutrophils' and lymphocytes' chemotactic factors from murine anagenic hair bulb extract].
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology·1991
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026